Skip to content

Assessing the Accuracy of the OptoWire DeuxTM in a Wire to Wire Comparison

Assessing the Accuracy of the OptoWire DeuxTM in a Wire to Wire Comparison

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03815032
Acronym
ACCURACY
Enrollment
45
Registered
2019-01-24
Start date
2019-02-01
Completion date
2020-03-31
Last updated
2020-07-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Angina, Stable, Angina, Unstable, Atherosclerosis, Atherosclerosis, Coronary, Coronary Artery Disease, Coronary Stenosis, NSTEMI - Non-ST Segment Elevation MI

Brief summary

The goal of the ACCURACY study is to assess the differences, if any, in FFR measurements made by the OptoWire Deux FFR guidewire by comparison of simultaneous data of two different OptoWire DeuxTM guidewires (group 1). In addition, the investigators will compare (group 2) the FFR measurements obtained from an OptoWire Deux FFR guidewire and compare it to the FFR measurement by a VERRATA-TM guidewire to assess coronary stenosis in the routine clinical practice.

Detailed description

This is a single center, prospective, non-blinded clinical investigation enrolling consecutive patients with coronary lesion candidate for FFR assessment. The study aim to assess the differences, if any, in FFR measurements made by the OptoWire Deux FFR guidewire by comparison of simultaneous data of two different OptoWire DeuxTM guidewires (group 1, n=30). In addition, The investigators will compare (group 2, n=15) the FFR measurements obtained from an OptoWire Deux FFR guidewire and compare it to the FFR measurement by a VERRATA-TM guidewire to assess coronary stenosis in the routine clinical practice. The clinical investigation will be conducted in the Centre Hospitalier de l'Université de Montréal (CHUM). No clinical follow-up is requested after the end of the procedure.

Interventions

DEVICEDrift assessment of OptoWire Deux FFR wire (1)

Simultaneous data of two different OptoWire DeuxTM guidewires (group 1) to assess a single coronary stenosis and detect any difference if any.

DEVICEDrift assessment of OptoWire Deux FFR wire (2)

Simultaneous data of one Optowire Deux TM guide wires and one VERRATA-TM FFR wire (group 2) to assess a single coronary stenosis and detect any difference if any.

Sponsors

Opsens, Inc.
CollaboratorINDUSTRY
Centre hospitalier de l'Université de Montréal (CHUM)
Lead SponsorOTHER

Study design

Allocation
NON_RANDOMIZED
Intervention model
SINGLE_GROUP
Primary purpose
DIAGNOSTIC
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Single de novo coronary lesion or in-stent restenosis lesion with an operator assessed reference diameter ≥2.0 mm requiring FFR measurement based on the operator's clinical judgment

Exclusion criteria

* Patients with ST-segment-elevation myocardial infarction (STEMI), culprit lesion of non-ST-segment-elevation myocardial infarction (NSTEMI), New York Heart Association class IV heart failure, suspected or visible thrombus, dissection or excessive calcification or tortuosity in the target vessel, or a stenosis in a bypass graft will be excluded.

Design outcomes

Primary

MeasureTime frameDescription
delta FFRDay 1To assess the magnitude of reading delta from wire to wire in a percutaneous coronary intervention

Secondary

MeasureTime frameDescription
Drift recordingDay 1The rate of significant drift, defined as Pd/Pa \<0.97 or \>1.03
Delta from guidewire to guidewireDay 1Assess the magnitude of reading delta from guidewire to guidewire prior to equalization.
StentsDay 1The number of stents used.
Stents on FFR wireDay 1The number of stents placed over an OptoWire DeuxTM guidewire.
Workhorse guidewireDay 1Number of Workhorse guidewire used.

Countries

Canada

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026